S
ATOS icon

SignatureFD’s Atossa Therapeutics ATOS Stock Holding History

SignatureFD’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27
Closed -$608 – 3314
2024
Q3 		$608 Buy
+27
New +$545 ﹤0.01% 3070
2022
Q2 		– Sell
-33
Closed -$1K – 3103
2022
Q1 		$1K Hold
33
– – ﹤0.01% 2942
2021
Q4 		$1K Buy
33
+13
+65% +$476 ﹤0.01% 2869
2021
Q3 		$1K Buy
+20
New +$1.16K ﹤0.01% 2771
2021
Q2 		– Sell
-40
Closed -$1K – 2942
2021
Q1 		$1K Buy
+40
New +$1.46K ﹤0.01% 2588

Other funds holding ATOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SignatureFD's ATOS Position: Q4 2024 in Review

SignatureFD sold out of Atossa Therapeutics (ATOS) in Q4 2024, closing a stake of 27 shares — an estimated $608 sold.

SignatureFD first reported a position in ATOS in Q1 2021 and held it in 5 quarters. The position peaked at $1K in Q1 2022. 86 funds tracked by Wall St. Rank hold ATOS as of Q4 2024.

  • SignatureFD reported no remaining Atossa Therapeutics position as of Q4 2024 after selling out during the quarter.
  • SignatureFD sold 27 Atossa Therapeutics shares in Q4 2024, an estimated $608.
  • SignatureFD first reported a position in Atossa Therapeutics in Q1 2021 and held it in 5 quarters.
  • SignatureFD's Atossa Therapeutics position peaked at $1K in Q1 2022.
  • 86 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q4 2024.

Based on SignatureFD's 13F filing for Q4 2024, filed 10 Feb 2025.